OrganiGram Holdings Inc
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Ediso… Read more
Market Cap & Net Worth: OrganiGram Holdings Inc (OGI)
OrganiGram Holdings Inc (NASDAQ:OGI) has a market capitalization of $193.25 Million ($193.25 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16919 globally and #6470 in its home market, demonstrating a -0.69% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying OrganiGram Holdings Inc's stock price $1.43 by its total outstanding shares 135141944 (135.14 Million).
OrganiGram Holdings Inc Market Cap History: 2015 to 2026
OrganiGram Holdings Inc's market capitalization history from 2015 to 2026. Data shows growth from $89.19 Million to $193.25 Million (14.67% CAGR).
Index Memberships
OrganiGram Holdings Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.01% | #458 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1587 of 3165 |
Weight: OrganiGram Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
OrganiGram Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how OrganiGram Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.22x
OrganiGram Holdings Inc's market cap is 1.22 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $290.41 Million | $6.13 Million | $846.66K | 47.39x | 343.00x |
| 2017 | $437.31 Million | $5.39 Million | -$10.89 Million | 81.15x | N/A |
| 2018 | $482.20 Million | $12.43 Million | $20.51 Million | 38.80x | 23.51x |
| 2019 | $1.32 Billion | $80.41 Million | -$9.54 Million | 16.47x | N/A |
| 2020 | $718.96 Million | $86.80 Million | -$136.16 Million | 8.28x | N/A |
| 2021 | $945.99 Million | $79.16 Million | -$130.70 Million | 11.95x | N/A |
| 2022 | $432.45 Million | $145.81 Million | -$14.28 Million | 2.97x | N/A |
| 2023 | $177.04 Million | $149.21 Million | -$229.48 Million | 1.19x | N/A |
| 2024 | $217.58 Million | $159.84 Million | -$45.44 Million | 1.36x | N/A |
| 2025 | $227.04 Million | $186.09 Million | -$17.78 Million | 1.22x | N/A |
Competitor Companies of OGI by Market Capitalization
Companies near OrganiGram Holdings Inc in the global market cap rankings as of March 19, 2026.
Key companies related to OrganiGram Holdings Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
OrganiGram Holdings Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, OrganiGram Holdings Inc's market cap moved from $89.19 Million to $ 193.25 Million, with a yearly change of 14.67%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $193.25 Million | -14.88% |
| 2025 | $227.04 Million | +4.35% |
| 2024 | $217.58 Million | +22.90% |
| 2023 | $177.04 Million | -59.06% |
| 2022 | $432.45 Million | -54.29% |
| 2021 | $945.99 Million | +31.58% |
| 2020 | $718.96 Million | -45.71% |
| 2019 | $1.32 Billion | +174.66% |
| 2018 | $482.20 Million | +10.27% |
| 2017 | $437.31 Million | +50.58% |
| 2016 | $290.41 Million | +225.59% |
| 2015 | $89.19 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of OrganiGram Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $193.25 Million USD |
| MoneyControl | $193.25 Million USD |
| MarketWatch | $193.25 Million USD |
| marketcap.company | $193.25 Million USD |
| Reuters | $193.25 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.